BREAKING! European Randomized Clinical Study Shows That Echinacea Reduces Risk Of Viral Respiratory Tract Infections Including COVID-19!
Source: COVID-19 Herbs - Echinacea Dec 15, 2021 2 years, 11 months, 1 week, 6 hours, 58 minutes ago
COVID-19 Herbs: A new European randomized, open, controlled, exploratory clinical study conducted by researchers from the Clinical Research Center DCC Convex Ltd-Bulgaria, Virtus Respiratory Research Limited-United Kingdom, Imperial College London-United Kingdom, Medistat Ltd-Bulgaria, Charité – Universitätsmedizin Berlin-Germany, the Italian Ministry of Defence, University of Antwerp-Belgium and the University of Ljubljana-Slovenia has shown that the herb Echinacea purpurea demonstrates antiviral properties and is able to reduce the risk of viral respiratory tract infections including that by the SARS-CoV-2 pathogen which causes the COVID-19 disease.
https://clinicaltrials.gov/ct2/show/NCT05002179
.jpg)
The study team suggest that along with vaccines, the additional regimen of taking Echinacea supplements can act as an effective prophylaxis against the SARS-CoV-2 coronavirus and its emerging variants.
Please Help! Do Not Ignore Our Appeals For Help. Please support the sustainability of this website and all our research and community initiatives by making a donation to our cause. Your donation helps saves lives directly and indirectly. Every dollar counts. Please Support. Thank You. (We apologize for the constant appeal and distractions but despite having tons of readers, we have only reached 3.5% of our goals! We are not funded by any government grants of private companies unlike in the West.)
https://www.thailandmedical.news/p/sponsorship
The study findings were published on a preprint server and are currently being peer reviewed.
https://www.medrxiv.org/content/10.1101/2021.12.10.21267582v1
Thailand Medical News had as early as March 2020 covered about the possible use of Echinacea as a prophylaxis against the COVID-19 disease but certain so-called ‘experts’ from UK had claimed that the herb Echinacea could actually aggravate the cytokine storms and worsen the situation. We however believed that as far as you did not yet get the virus, it would serve as an excellent prophylaxis but should you have already tested positive for the virus, then you should not be using it to aggravate the inflammatory states.
https://www.thailandmedical.news/news/breaking-coronavirus-research-could-echinacea-act-as-a-prophylaxis-against-the-sars-cov-2-coronavirus-more-research-warranted
It should be noted that since then, no evidence or research paper has ever been published to show that Echinacea aggravates the cytokine storms as claimed by the so-called ‘experts’ from UK. (The only thing we have seen is that the UK has more infections and deaths from COVID-19 and soon it will be more catastrophic, thanks to all their so called qualified ‘scientific experts’!)
A Saudi Arabia study had also demonstrated that Echinacea was an possible therapeutic agent f
or COVID-19.
https://www.thailandmedical.news/news/covid-19-herbs-saudi-arabia-study-demonstrates-possible-use-of-echinacea-and-st-john-s-wort-as-therapeutic-agents-against-covid-19
Previous in vitro studies showed that Echinacea purpurea demonstrated strong antiviral activity against enveloped viruses, including SARS CoV2.
https://pubmed.ncbi.nlm.nih.gov/32907596/
The
COVID-19 Herbs study team from the current European randomized clinical trial examined the potential of Echinacea purpurea in preventing and treating respiratory tract infections (RTIs) and in particular, SARS CoV2 infections.
A total of 120 healthy volunteers (m,f, 18 to 75 years) were randomly assigned to Echinacea prevention or control group without any intervention in the open label randomized clinical trial.
After a run-in week, participants went through 3 prevention cycles of 2, 2 and 1 months with daily 2400mg Echinacea purpurea extract (Echinaforce, EF).
The prevention cycles were interrupted by breaks of 1 week. Acute respiratory symptoms were treated with 4000 mg EF for up to 10 days, and their severity assessed via a diary.
Naso/oropharyngeal swabs and venous blood samples were routinely collected every month and during acute illnesses for detection and identification of respiratory viruses, including SARS CoV2 via RT qPCR and serology.
The study findings summarized over all phases of prevention showed that 21 and 29 samples tested positive for any virus in the EF and control group, of which 5 and 14 samples tested SARS-CoV-2 positive (RR=0.37, Chi square test, p=0.03).
Overall, 10 and 14 symptomatic episodes occurred, of which 5 and 8 were COVID 19 (RR=0.70, Chi-square test, p>0.05). EF treatment when applied during acute episodes significantly reduced the overall virus load by at least 2.12 log10 or approx. 99% (t test, p<0.05), the time to virus clearance by 8.0 days for all viruses (Wilcoxon test, p=0.02) and by 4.8 days for SARS CoV2 (p>0.05) in comparison to control.
Finally, EF treatment significantly reduced fever days (1 day vs 11 days, Chi square test, p=0.003) but not the overall symptom severity. There were fewer COVID-19 related hospitalizations in the EF treatment group (N=0 vs N=2).
The study findings demonstrated the antiviral effects of Echinacea purpurea and that it reduces the risk of viral RTIs, including SARS CoV2.
The study team conclude, “By substantially reducing virus loads in infected subjects, Echinacea purpurea offers a supportive addition to existing mandated treatments like vaccinations. Future confirmatory studies are warranted.”
Please Help! Do Not Ignore Our Appeals For Help. Please support the sustainability of this website and all our research and community initiatives by making a donation to our cause. Your donation helps saves lives directly and indirectly. Every dollar counts. Please Support. Thank You. (We apologize for the constant appeal and distractions but despite having tons of readers, we have only reached 3.5% of our goals! We are not funded by any government grants of private companies unlike in the West.)
https://www.thailandmedical.news/p/sponsorship
Note: Do not attempt to consume Echinacea or any other herbs, supplements or drugs to prevent or treat COVID-19 without consulting a licensed doctor first.
Help Share This Article To As Many People As Possible. Echinacea might be a potential prophylaxis against COVID-19.
For more about
COVID-19 Herbs and other therapeutics, go to the following links on for a wealth of information that could save your lives.
https://www.thailandmedical.news/articles/covid-19-herbs
https://www.thailandmedical.news/articles/covid-19-supplements
https://www.thailandmedical.news/articles/covid19-drugs
https://www.thailandmedical.news/news/a-simple-guide-to-supplements,-herbs-and-repurposed-drugs-that-can-help-with-covid-19
